• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

恶性疟原虫:通过聚合酶链反应(PCR)和限制性酶切检测二氢叶酸还原酶及二氢蝶酸合酶基因中的多态性

Plasmodium falciparum: detection of polymorphisms in the dihydrofolate reductase and dihydropteroate synthetase genes by PCR and restriction digestion.

作者信息

Duraisingh M T, Curtis J, Warhurst D C

机构信息

Department of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, United Kingdom.

出版信息

Exp Parasitol. 1998 May;89(1):1-8. doi: 10.1006/expr.1998.4274.

DOI:10.1006/expr.1998.4274
PMID:9603482
Abstract

With the spread of resistance to chloroquine, the combination of sulphadoxine and pyrimethamine is growing in importance for the treatment of infection with the malaria parasite Plasmodium falciparum. Mutations in the dhfr gene of P. falciparum have been associated with resistance to pyrimethamine. Recently, several polymorphisms have been identified in the P. falciparum dhps gene which may correlate with sulphadoxine-resistance. Simple and rapid tests have been developed to detect these polymorphisms, using PCR followed by restriction digestion. These tests can accurately identify all the polymorphisms described to date at codons 16, 51, 59, 108, and 164 in the dhfr gene and those at codons 436, 437, 540, 581, and 613 in the dhps gene. A nested system has been developed which allows the accurate detection of these polymorphisms in samples of fingerprick blood collected on glass fiber membranes and filter papers, some with very low parasitaemias.

摘要

随着对氯喹耐药性的传播,磺胺多辛与乙胺嘧啶的联合用药在治疗恶性疟原虫感染方面的重要性日益增加。恶性疟原虫二氢叶酸还原酶(dhfr)基因的突变与对乙胺嘧啶的耐药性有关。最近,在恶性疟原虫二氢蝶酸合酶(dhps)基因中发现了几种多态性,这些多态性可能与对磺胺多辛的耐药性相关。已开发出简单快速的检测方法来检测这些多态性,方法是先进行聚合酶链反应(PCR),然后进行限制性酶切。这些检测方法能够准确识别迄今所描述的dhfr基因中第16、51、59、108和164密码子以及dhps基因中第436、437、540、581和613密码子处的所有多态性。已开发出一种巢式系统,可准确检测在玻璃纤维膜和滤纸上采集的微量血样中的这些多态性,其中一些血样的疟原虫血症水平非常低。

相似文献

1
Plasmodium falciparum: detection of polymorphisms in the dihydrofolate reductase and dihydropteroate synthetase genes by PCR and restriction digestion.恶性疟原虫:通过聚合酶链反应(PCR)和限制性酶切检测二氢叶酸还原酶及二氢蝶酸合酶基因中的多态性
Exp Parasitol. 1998 May;89(1):1-8. doi: 10.1006/expr.1998.4274.
2
A simple, high-throughput method to detect Plasmodium falciparum single nucleotide polymorphisms in the dihydrofolate reductase, dihydropteroate synthase, and P. falciparum chloroquine resistance transporter genes using polymerase chain reaction- and enzyme-linked immunosorbent assay-based technology.一种利用基于聚合酶链反应和酶联免疫吸附测定的技术检测恶性疟原虫二氢叶酸还原酶、二氢蝶酸合酶和恶性疟原虫氯喹抗性转运蛋白基因中单个核苷酸多态性的简单、高通量方法。
Am J Trop Med Hyg. 2005 Feb;72(2):155-62.
3
The implication of dihydrofolate reductase and dihydropteroate synthetase gene mutations in modification of Plasmodium falciparum characteristics.二氢叶酸还原酶和二氢蝶酸合酶基因突变对恶性疟原虫特征改变的影响
Malar J. 2007 Aug 8;6:108. doi: 10.1186/1475-2875-6-108.
4
Plasmodium falciparum: underestimation of dihydrofolate reductase and dihydropteroate synthase polymorphism in field samples: a technical shortcoming of nested PCR assays with mutation-specific primers.恶性疟原虫:野外样本中二氢叶酸还原酶和二氢蝶酸合酶多态性的低估:使用突变特异性引物的巢式PCR检测的技术缺陷
Exp Parasitol. 2001 Nov;99(3):115-22. doi: 10.1006/expr.2001.4660.
5
Associations of antifolate resistance in vitro and point mutations in dihydrofolate reductase and dihydropteroate synthetase genes of Plasmodium falciparum.恶性疟原虫体外抗叶酸抗性与二氢叶酸还原酶及二氢蝶酸合酶基因突变的关联
J Postgrad Med. 2004 Jan-Mar;50(1):17-20.
6
Prediction of Plasmodium falciparum resistance to sulfadoxine/pyrimethamine in vivo by mutations in the dihydrofolate reductase and dihydropteroate synthetase genes: a comparative study between sites of differing endemicity.通过二氢叶酸还原酶和二氢蝶酸合酶基因突变对恶性疟原虫体内磺胺多辛/乙胺嘧啶耐药性的预测:不同流行程度地区之间的比较研究
Am J Trop Med Hyg. 2003 Dec;69(6):601-6.
7
Two mutations in dihydrofolate reductase combined with one in the dihydropteroate synthase gene predict sulphadoxine-pyrimethamine parasitological failure in Ugandan children with uncomplicated falciparum malaria.二氢叶酸还原酶中的两个突变与二氢蝶酸合酶基因中的一个突变相结合,预示着乌干达单纯性恶性疟原虫疟疾儿童使用周效磺胺-乙胺嘧啶治疗时出现寄生虫学治疗失败。
Infect Genet Evol. 2004 Dec;4(4):321-7. doi: 10.1016/j.meegid.2004.04.002.
8
Point mutations in the dihydrofolate reductase and dihydropteroate synthase genes of Plasmodium falciparum and resistance to sulfadoxine-pyrimethamine in Sri Lanka.恶性疟原虫二氢叶酸还原酶和二氢蝶酸合酶基因中的点突变与斯里兰卡对磺胺多辛-乙胺嘧啶的耐药性
Am J Trop Med Hyg. 2006 Feb;74(2):198-204.
9
[Monitoring the chemoresistance of Plasmodium falciparum malaria in Yopougon (Abidjan): in vivo study of chloroquine sensitivity and evaluation of pyrimethamine resistance following the analysis of point mutation in the dihydrofolate reductase gene].[监测阿比让约普贡地区恶性疟原虫疟疾的化疗耐药性:二氢叶酸还原酶基因点突变分析后氯喹敏感性的体内研究及乙胺嘧啶耐药性评估]
Sante. 2002 Oct-Dec;12(4):363-7.
10
DHFR and DHPS genotypes of Plasmodium falciparum isolates from Gabon correlate with in vitro activity of pyrimethamine and cycloguanil, but not with sulfadoxine-pyrimethamine treatment efficacy.来自加蓬的恶性疟原虫分离株的二氢叶酸还原酶(DHFR)和二氢蝶酸合酶(DHPS)基因型与乙胺嘧啶和环氯胍的体外活性相关,但与磺胺多辛-乙胺嘧啶治疗效果无关。
J Antimicrob Chemother. 2003 Jul;52(1):43-9. doi: 10.1093/jac/dkg294. Epub 2003 Jun 12.

引用本文的文献

1
and markers of resistance to sulfadoxine-pyrimethamine five years (2016-2020) after the implementation of seasonal malaria chemoprevention in Cameroon.以及喀麦隆实施季节性疟疾化学预防五年(2016 - 2020年)后对磺胺多辛-乙胺嘧啶耐药性的标志物。
Wellcome Open Res. 2024 Jun 20;9:323. doi: 10.12688/wellcomeopenres.22347.1. eCollection 2024.
2
Profile of molecular markers of Sulfadoxine-Pyrimethamine-resistant Plasmodium falciparum in individuals living in southern area of Brazzaville, Republic of Congo.刚果共和国布拉柴维尔南部地区居民中耐磺胺多辛-乙胺嘧啶恶性疟原虫的分子标志物概况
Int J Parasitol Drugs Drug Resist. 2024 Dec;26:100569. doi: 10.1016/j.ijpddr.2024.100569. Epub 2024 Oct 26.
3
Evolution of Pfdhps and Pfdhfr mutations before and after adopting seasonal malaria chemoprevention in Nanoro, Burkina Faso.
在布基纳法索纳诺罗采用季节性疟疾化学预防措施前后,Pfdhps 和 Pfdhfr 突变的演变。
Sci Rep. 2024 Oct 16;14(1):24224. doi: 10.1038/s41598-024-75369-2.
4
Molecular Surveillance of Malaria Using the PF AmpliSeq Custom Assay for Parasites from Dried Blood Spot DNA Isolates from Peru.利用PF AmpliSeq定制检测法对秘鲁干血斑DNA分离株中的疟原虫进行疟疾分子监测。
Bio Protoc. 2023 Mar 5;13(5):e4621. doi: 10.21769/BioProtoc.4621.
5
Creating and Validating Ligase Primers to Detect Single Nucleotide Polymorphisms Associated with Atovaquone Resistance in Plasmodium falciparum.构建和验证连接酶引物以检测与恶性疟原虫阿托伐醌耐药性相关的单核苷酸多态性。
Am J Trop Med Hyg. 2023 Mar 6;108(4):777-782. doi: 10.4269/ajtmh.22-0700. Print 2023 Apr 5.
6
Sub-microscopic Plasmodium falciparum parasitaemia, dihydropteroate synthase (dhps) resistance mutations to sulfadoxine-pyrimethamine, transmission intensity and risk of malaria infection in pregnancy in Mount Cameroon Region.喀麦隆山区孕妇亚微观间日疟原虫血症、对磺胺多辛-乙胺嘧啶的二氢叶酸还原酶(dhps)耐药突变、传播强度与疟疾感染风险。
Malar J. 2023 Mar 2;22(1):73. doi: 10.1186/s12936-023-04485-7.
7
Malaria Molecular Surveillance in the Peruvian Amazon with a Novel Highly Multiplexed Plasmodium falciparum AmpliSeq Assay.利用新型高度多重恶性疟原虫扩增子测序分析法对秘鲁亚马逊地区进行疟疾分子监测
Microbiol Spectr. 2023 Feb 22;11(2):e0096022. doi: 10.1128/spectrum.00960-22.
8
Ten-year persistence and evolution of Plasmodium falciparum antifolate and anti-sulfonamide resistance markers pfdhfr and pfdhps in three Asian countries.在三个亚洲国家中,恶性疟原虫抗叶酸和抗磺胺类药物耐药标记物 pfdhfr 和 pfdhps 的十年持续存在和演变。
PLoS One. 2022 Dec 16;17(12):e0278928. doi: 10.1371/journal.pone.0278928. eCollection 2022.
9
[Monitoring the Efficacy of Artemether-Lumefantrine in the Treatment of Uncomplicated Malaria by Kelch 13 Gene Mutations in Bangui, Central African Republic].[通过监测中非共和国班吉地区 Kelch 13 基因突变来评估蒿甲醚-本芴醇治疗非复杂性疟疾的疗效]
Med Trop Sante Int. 2021 Mar 26;1(1). doi: 10.48327/mtsibulletin.n1.2021.82. eCollection 2021 Mar 31.
10
Molecular Markers for Sulfadoxine/Pyrimethamine and Chloroquine Resistance in Plasmodium falciparum in Thailand.泰国恶性疟原虫对磺胺多辛/乙胺嘧啶和氯喹耐药的分子标志物。
Korean J Parasitol. 2022 Apr;60(2):109-116. doi: 10.3347/kjp.2022.60.2.109. Epub 2022 Apr 20.